You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK (GenomeWeb) – Exosome Diagnostics and Chesapeake Urology announced today that they have initiated an evidence development study designed to drive health plan coverage for Exosome's ExoDx Prostate IntelliScore (EPI) prostate cancer test.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.